Premium
FibroBiologics Inc (FBLG)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound... FibroBiologics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of fibroblast-based therapies for patients suffering from chronic diseases. The company’s product pipeline includes CYWC628 which has completed pre-clinical trial for the treatment of wound healing; CYMS101 which has completed Phase 1 trial for the treatment of multiple sclerosis; CybroCell for the treatment of degenerative disc disease; and CYPS317 for the treatment of psoriasis. It also develops early-stage research products, including CYTER915 to treat the human longevity; and TCB190 for the treatment of certain cancers. FibroBiologics, Inc. was incorporated in 2021 and is headquartered in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.11 | -9.64912280702 | 1.14 | 1.17 | 1 | 157521 | 1.08060589 | CS |
| 4 | -0.2 | -16.2601626016 | 1.23 | 1.25 | 0.9523 | 294819 | 1.03918578 | CS |
| 12 | 0.69 | 202.941176471 | 0.34 | 3.965 | 0.185 | 658854 | 0.96406154 | CS |
| 26 | 0.772 | 299.224806202 | 0.258 | 3.965 | 0.185 | 1279208 | 0.45154244 | CS |
| 52 | 0.17 | 19.7674418605 | 0.86 | 3.965 | 0.185 | 1034001 | 0.46055403 | CS |
| 156 | -28.97 | -96.5666666667 | 30 | 55 | 0.185 | 582801 | 1.27065232 | CS |
| 260 | -28.97 | -96.5666666667 | 30 | 55 | 0.185 | 582801 | 1.27065232 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
